Combined measurement of serum DNA and urine VP1 messenger RNA in monitoring BK virus replication in kidney graft recipients

Transplantation Proceedings

Volumn 43, Issue 4, 2011, Pages 1052-1054

  Astegiano, S ^a   Bergallo, M ^a   Terlizzi, M E ^a   Sidoti, F ^a   Gambarino, S ^a   Messina, M ^a   Costa, C ^a   Segoloni, G P ^a   Cavallo, R ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLOSPORIN A; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN VP1; RAPAMYCIN; STEROID; TACROLIMUS; VIRUS DNA; VIRUS RNA;

ADULT; BK VIRUS; BK VIRUS ASSOCIATED NEPHROPATHY; CLINICAL TRIAL; CONFERENCE PAPER; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; MONITORING; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; URINE LEVEL; VIREMIA; VIRUS DETECTION; VIRUS LOAD; VIRUS REPLICATION;

AGED; BIOLOGICAL MARKERS; BK VIRUS; CAPSID PROTEINS; DNA, VIRAL; FEMALE; HUMANS; ITALY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RNA, MESSENGER; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD; VIRUS REPLICATION;

EID: 79957609958     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.01.118     Document Type: Conference Paper

References (12)

1. Nickeleit V, Singh HK, Mihatsch MJ: Polyomavirus nephropathy: morphology, pathophysiology, and clinical management. Curr Opin Nephrol Hypertens 12:599, 2003
2. Hirsch HH, Brennan DC, Drachenberg CB, et al: Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79:1277, 2005
3. Ramos E, Drachenberg CB, Wali R, et al: The decade of polyomavirus-associated nephropathy: state of affairs. Transplantation 87:621, 2009
4. Viscount HB, Eid AJ, Espy MJ, et al: Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation 84:340, 2007
5. Costa C, Bergallo M, Astegiano S, et al: Monitoring of BK virus replication in the first year following renal transplantation. Nephrol Dial Transplant 23:3333, 2008
6. Ding R, Medeiros M, Dadhania D, et al: Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation 74:987, 2002
7. Dadhania D, Snopkowski C, Ding R, et al: Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication. Transplantation 86:521, 2008
8. Dadhania D, Snopkowski C, Ding R, et al: Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation 90:189, 2010
9. Hirsch HH, Drachenberg CB, Steiger J, et al: Polyomavirus-associated nephropathy in renal transplantation: critical issues of screening and management. Adv Exp Med Biol 577:160, 2006
10. Bergallo M, Astegiano S, Sidoti F, et al: Real-time RT-PCR assay for the quantitation of polyomavirus BK VP1 mRNA levels in urine. Mol Biotechnol 45:82, 2010
11. Hirsch HH: VP1 messenger RNA levels in urine for diagnosing BK virus nephropathy? Transplantation 75:2160, 2003
12. Nickeleit V, Steiger J, Mihatsch MJ: Re: noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1. Transplantation 75:2160, 2003